Researcher cautions trial for MS ‘liberation’ therapy years away
Researcher cautions trial for MS ‘liberation’ therapy years away
Saskatoon researcher Dr. Katherine Knox urged multiple sclerosis patients to have patience Wednesday, as a clinical trial of the so-called “liberation treatment” is years down the road, despite promised funding from the Saskatchewan government.
The biggest difficulty her team faces, she said, is that they don’t know how to test patients to see if they have the blocked veins which, according to the theory behind liberation treatment, are linked to the disease.
“The problem is that at the present time, we do not know how to accurately and reliably define venous abnormalities that may or may not be related to MS,” said Knox, who is the director of Saskatoon’s MS Clinic and the Cameco MS Neuroscience Research Centre, a research unit of the University of Saskatchewan.